Skip to content

A Prospective, Contralateral, Eye to Eye Comparison of SMILE Surgery to LASIK Surgery

A Prospective, Randomized Comparison of SMILE Surgery to Wavefront-guided LASIK Surgery

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03067077
Enrollment
44
Registered
2017-03-01
Start date
2017-03-12
Completion date
2021-03-15
Last updated
2022-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myopia

Keywords

SMILE, LASIK, Myopia, Wavefront-guided

Brief summary

Subjects will undergo SMILE surgery in one eye and LASIK surgery in their other eye to correct myopia.

Detailed description

Subjects will have a comprehensive eye examination once they express an interest in the study. This includes a slit lamp examination of the front of the eye and a dilated fundoscopic examination of the back of the eye. If there is any pathology noted that would exclude the subject from the study, then we will inform the patient and make an appropriate referral. if the subject is deemed appropriate for the study after a comprehensive examination included computerized videokeratography, then they can be enrolled. Subjects will undergo bilateral simultaneous eye surgery. Which eye is treated with the WFG-LASIK and which eye is treated with SMILE will be randomized so there is a 50% chance for either eye to receive one treatment. Subjects will be seen on the day of surgery, post op day one, one week, one month, three months, six months and one year. Subjects will receive topical antibiotics in each eye for one week following the procedure. Subjects will receive topical steroid ophthalmic drops for one week after treatment. Subjects will also receive topical antibiotic ophthalmic drops for four days after treatment. All of this is within the usual and customary standard of care for the treatment of subjects undergoing LASIK and SMILE surgery.

Interventions

PROCEDURESMILE

SMILE surgery

PROCEDURELASIK

LASIK surgery

Sponsors

Stanford University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
22 Years to 59 Years
Healthy volunteers
Yes

Inclusion criteria

* Subjects age 22 and older with healthy eyes. Nearsightedness between -0.75 diopters and -8.00 diopters. * Subjects with up to 3.00 diopters of astigmatism.

Exclusion criteria

* Subjects under the age of 22. * Subjects with excessively thin corneas. * Subjects with topographic evidence of keratoconus. * Subjects with ectatic eye disorders. * Subjects with autoimmune diseases. * Subjects who are pregnant or nursing. * Subjects must have similar levels of nearsightedness in each eye. They can not be more than 1.5 diopter of difference between eyes. * Subjects with 3.25 or more diopters of astigmatism * Subjects must have similar levels of astigmatism in each eye. They can not have more than 0.50 diopters of difference between eyes.

Design outcomes

Primary

MeasureTime frameDescription
Percentage of Participant Eyes With an Uncorrected Visual Acuity of 20/20 or BetterOne yearETDRS testing lane

Secondary

MeasureTime frameDescription
Anterior Segment Ocular Coherence Topography AnalysisOne yearHumphrey Visante AS OCT
Number of Participant Eyes Losing 2 or More Lines of Corrected Distance Visual AcuityOne yearETDRS testing lane
Aberrometry MeasurementsOne yearIncrease in total higher order RMS (root mean squared) by greater than 0.5 microns
Patient SatisfactionOne yearPercentage of patients satisfied with surgery. Patients were asked yes or no.
Analysis of AstigmatismOne yearParticipant eyes with an increase in astigmatism of greater than 1.0 diopter
Dry Eye Symptoms as Measured by OSDI IndexOne yearWorsening of ocular surface disease index (OSDI) score of greater than 25. The overall OSDI score defined the ocular surface as normal (0-12 points) or as having mild (13-22 points), moderate (23-32 points), or severe (33-100 points) disease.
PredictabilityOne yearNumber of eyes within +/- 0.5 and +/- 1.00 diopter of the intended correction
StabilityOne yearChange in refractive error greater than one diopter over 1 to 12 months
Change in Corneal SensationOne yearA decrease in corneal sensation of more than 4 cm as measured by Cochet-Bonnet Aesthesiometry

Countries

United States

Participant flow

Recruitment details

Enrolled participants were to receive SMILE surgery in one eye and LASIK surgery in their fellow eye

Participants by arm

ArmCount
All Participants
Participants receive SMILE surgery in one eye and Wavefront-guided LASIK in the fellow eye.
44
Total44

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyDid not receive surgery45
Overall StudyLost to Follow-up32

Baseline characteristics

CharacteristicAll Participants
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
44 Participants
Race/Ethnicity, Customized
Asian
19 Participants
Race/Ethnicity, Customized
Caucasian
18 Participants
Race/Ethnicity, Customized
Hispanic
2 Participants
Race/Ethnicity, Customized
Indian
4 Participants
Race/Ethnicity, Customized
Pacific Islander
1 Participants
Region of Enrollment
United States
44 Participants
Sex: Female, Male
Female
21 Participants
Sex: Female, Male
Male
23 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 440 / 44
other
Total, other adverse events
1 / 440 / 44
serious
Total, serious adverse events
0 / 440 / 44

Outcome results

Primary

Percentage of Participant Eyes With an Uncorrected Visual Acuity of 20/20 or Better

ETDRS testing lane

Time frame: One year

Population: Participants who completed 12 month follow-up

ArmMeasureValue (NUMBER)
SMILEPercentage of Participant Eyes With an Uncorrected Visual Acuity of 20/20 or Better94 percentage of participant eyes
Wavefront-guided LASIKPercentage of Participant Eyes With an Uncorrected Visual Acuity of 20/20 or Better83 percentage of participant eyes
Secondary

Aberrometry Measurements

Increase in total higher order RMS (root mean squared) by greater than 0.5 microns

Time frame: One year

Population: Participants who completed 12 months follow-up

ArmMeasureValue (COUNT_OF_UNITS)
SMILEAberrometry Measurements0 Eyes
Wavefront-guided LASIKAberrometry Measurements0 Eyes
Secondary

Analysis of Astigmatism

Participant eyes with an increase in astigmatism of greater than 1.0 diopter

Time frame: One year

Population: Participants with 12 months follow-up

ArmMeasureValue (COUNT_OF_UNITS)
SMILEAnalysis of Astigmatism0 Eyes
Wavefront-guided LASIKAnalysis of Astigmatism0 Eyes
Secondary

Anterior Segment Ocular Coherence Topography Analysis

Humphrey Visante AS OCT

Time frame: One year

Population: The outcome could not be analyzed because the data were corrupted

Secondary

Change in Corneal Sensation

A decrease in corneal sensation of more than 4 cm as measured by Cochet-Bonnet Aesthesiometry

Time frame: One year

Population: Participants who completed 12 months follow-up

ArmMeasureValue (COUNT_OF_UNITS)
SMILEChange in Corneal Sensation0 Eyes
Wavefront-guided LASIKChange in Corneal Sensation0 Eyes
Secondary

Dry Eye Symptoms as Measured by OSDI Index

Worsening of ocular surface disease index (OSDI) score of greater than 25. The overall OSDI score defined the ocular surface as normal (0-12 points) or as having mild (13-22 points), moderate (23-32 points), or severe (33-100 points) disease.

Time frame: One year

Population: Patients who completed 12 months follow-up

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
SMILEDry Eye Symptoms as Measured by OSDI Index0 Participants
Wavefront-guided LASIKDry Eye Symptoms as Measured by OSDI Index0 Participants
Secondary

Number of Participant Eyes Losing 2 or More Lines of Corrected Distance Visual Acuity

ETDRS testing lane

Time frame: One year

Population: Participants who completed the 12 month follow-up

ArmMeasureValue (COUNT_OF_UNITS)
SMILENumber of Participant Eyes Losing 2 or More Lines of Corrected Distance Visual Acuity0 Eyes
Wavefront-guided LASIKNumber of Participant Eyes Losing 2 or More Lines of Corrected Distance Visual Acuity0 Eyes
Secondary

Patient Satisfaction

Percentage of patients satisfied with surgery. Patients were asked yes or no.

Time frame: One year

Population: Participants who completed 12 months follow-up

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
SMILEPatient Satisfaction36 Participants
Wavefront-guided LASIKPatient Satisfaction36 Participants
Secondary

Predictability

Number of eyes within +/- 0.5 and +/- 1.00 diopter of the intended correction

Time frame: One year

Population: Participants who completed 12 months follow-up

ArmMeasureGroupValue (COUNT_OF_UNITS)
SMILEPredictability+/- 0.50 diopters30 Eyes
SMILEPredictability+/- 1.0 diopters36 Eyes
Wavefront-guided LASIKPredictability+/- 0.50 diopters34 Eyes
Wavefront-guided LASIKPredictability+/- 1.0 diopters37 Eyes
Secondary

Stability

Change in refractive error greater than one diopter over 1 to 12 months

Time frame: One year

Population: Participants who completed twelve months follow-up

ArmMeasureValue (COUNT_OF_UNITS)
SMILEStability0 Eyes
Wavefront-guided LASIKStability0 Eyes

Source: ClinicalTrials.gov · Data processed: Feb 20, 2026